Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Ordinary Shares, par value GBP 0.003 per share
-
Shares outstanding
-
792,553,191
-
Total 13F shares
-
100,520,356
-
Share change
-
+16,471,082
-
Total reported value
-
$361,910,507
-
Put/Call ratio
-
172%
-
Price per share
-
$3.60
-
Number of holders
-
76
-
Value change
-
+$59,834,784
-
Number of buys
-
33
-
Number of sells
-
42
Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) as of Q2 2024
As of 30 Jun 2024,
Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
100,520,356 shares.
The largest 10 holders included
Rubric Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Rock Springs Capital Management LP, MANGROVE PARTNERS IM, LLC, JANUS HENDERSON GROUP PLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), 683 Capital Management, LLC, ALKEON CAPITAL MANAGEMENT LLC, Frazier Life Sciences Management, L.P., and Clearline Capital LP.
This page lists
76
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.